Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sincere CoTSE:7782 +0.21%77 Net Margin % is 0.84% as of Dec. 2025, which is 75% below its 10-year median of 3.42. GuruFocus rates TSE:7782 with a GF Score™ of 77/100 and a GF Value™ of 円689.09 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Sincere Co ranks better than 52.39% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Sincere Co's Net Income for the
three
months ended in Dec. 2025 was 円17 Mil. Sincere Co's Revenue for the
three
months ended in Dec. 2025 was 円2,037 Mil. Therefore, Sincere Co's net margin for the quarter that ended in Dec. 2025 was 0.84%.
The historical rank and industry rank for Sincere Co's Net Margin % or its related term are showing as below:
TSE:7782'
s Net Margin % Range Over the Past 10 Years
Min: 0.38 Med: 3.42 Max: 5.05
Current: 3.12
TSE:7782's Net Margin % is ranked better than 52.39% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 2.13
vs TSE:7782: 3.12
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sincere Co Net Margin % Related Terms
Sincere Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Sincere Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7782 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Sincere Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sincere Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sincere Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sincere Co (TSE:7782) has a Net Margin % of 0.84% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Sincere Co and its competitors. This is 75% below median its historical median of 3.42. Over the past decade, Sincere Co's Net Margin % has ranged from 0.38 to 5.05. According to the industry distribution chart, Sincere Co ranks #388 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 47.6%.
Is Sincere Co's Net Margin % too high?
Sincere Co's current Net Margin % of 0.84% is 75% below median its 10-year median of 3.42. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 5.05. The Medical Devices & Instruments industry median Net Margin % is 2.13. Sincere Co's value of 0.84% is 60.6% below this industry median. Based on the distribution chart, Sincere Co ranks #388 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sincere Co has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #388 out of 815 companies for Net Margin %. This puts Sincere Co in the upper half of its industry. The industry median Net Margin % is 2.13. Sincere Co's value of 0.84% is 60.6% below this benchmark. Historically, Sincere Co's own Net Margin % has ranged from 0.38 to 5.05 over the past decade. While the company's 10-year median is 3.42 vs. the industry median of 2.13, Sincere Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.13, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sincere Co's current Net Margin % of 0.84% is 60.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current Net Margin % is 0.84%, which is 75% below median its own 10-year median of 3.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円689.09, compared to a current price of 円472.00 — trading 31.5% below its estimated fair value. The current Net Margin % is 0.84%, which is 75% below median its 10-year median of 3.42 and 60.6% below the Medical Devices & Instruments industry median of 2.13. Sincere Co's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current Net Margin % is 0.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sincere Co (TSE:7782) Overvalued in 2026?
Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued.
The current stock price of 円472.00 is trading 31.5% below its estimated GF Value™ of 円689.09.
GuruFocus considers Sincere Co to be Significantly Undervalued.
Key valuation signals for TSE:7782:
Net Margin %: 0.84% (75% below median its 10-year median of 3.42)
GF Value™: 円689.09 vs. price of 円472.00 (31.5% below fair value)
Industry Position: 60.6% below the Medical Devices & Instruments median (#388 of 815)
No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
77GF Score
Get the complete analysis for TSE:7782
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7782 has been successfully added to your 
